Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at The Liver Meeting®…
The Quick Take
A post hoc analysis of adults with MASH and liver scarring with a BMI below 27 kg/m² found that measures of liver injury, fibrosis, and disease activity improved at week 72 among participants receiving semaglutide 2.4 mg once weekly injection versus placebo Non-invasive fibrosis...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Small businesses hit with Aus Post underpaid postage fees despite photographic evidence - Yahoo Finance Australia
Small businesses hit with Aus Post underpaid postage fees despite photographic evidence Yahoo Finance Australia
Business
GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8
Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside Japan NEW…
Business
OceanFirst Financial director Nicos Katsoulis buys $178,277 in stock
Local
Yordenis Ugás announces his new profession in the United States: "Always a Cuban, decent and hard-working." - CiberCuba
Yordenis Ugás announces his new profession in the United States: "Always a Cuban, decent and hard-working." CiberCuba